Profil
Dr. Christopher Belyea is Independent Non-Executive Director at Antisense Therapeutics Ltd. He is on the Board of Directors at Antisense Therapeutics Ltd.
Dr. Belyea was previously employed as President & Director by Metabolic Pharmaceuticals Ltd., Project Manager by Circadian Technologies Ltd., and a Principal by Griffith Hack Lawyers Pty Ltd.
He received his doctorate degree from the University of Melbourne.
Ehemalige bekannte Positionen von Christopher Belyea
| Unternehmen | Position | Ende |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 12.11.2015 |
| POLYNOVO LIMITED | Präsident | 01.01.2008 |
| CERYVYN THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Griffith Hack Lawyers Pty Ltd.
Griffith Hack Lawyers Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Ausbildung von Christopher Belyea
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Percheron Therapeutics Ltd.
Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polynovo Ltd.
Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Griffith Hack Lawyers Pty Ltd.
Griffith Hack Lawyers Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
















